Amgen

It's just starting to dip its toes into the biopharma waters.

Oracle Cloud Infrastructure First to Run NVIDIA AI Supercomputing Instances; Microsoft Azure, Google Cloud and Others to Host DGX Cloud Soon GTC—NVIDIA today announced NVIDIA DGX™ Cloud, an AI supercomputing service that gives enterprises immediate access to the infrastructure and software needed to train advanced models…

Part of NVIDIA AI Foundations, New BioNeMo Cloud Service Accelerates Life Sciences Research, Drug Discovery and Protein Engineering; Amgen and a Dozen Startups Among Early Access Customers GTC—NVIDIA today announced an expanded set of generative AI cloud services for customizing AI foundation models to accelerate the…

CAMBRIDGE, Mass. , July 20, 2023 /PRNewswire/ -- Erez Kaminski , the founder and CEO of Ketryx, the first connected lifecycle management software for MedTechs, will join other industry experts in a workshop entitled, "Deconstructing AI in HealthTech: The Essential Questions." Co-hosted by HealthTech Build and MIT's Martin Trust Center for…

Amgen (AMGN) won an appeal court ruling on Wednesday, dealing a setback to Novartis (NVS) in a patent litigation related to its psoriasis drug Otezla. Read more here.

It has dominated our attention for the last three months like no other technological invention in close to half a century. ChatGPT and its close generative AI cousins (like Bard and MedPaLM) are now being deployed and tested in healthcare settings. At its simplest, generative AI is a tool or algorithm that can create astonishing…

“Quinn told attendees that Stoll has been a mentor and friend for many years and that the award represents Stoll’s role as the ‘patriarch of the first family of IP and a flame in the heart of the IP community.’” Renee and Gene Quinn with IPWatchdog Masters Hall of Fame Inductee, Bob Stoll (center) …

The Supreme Court’s recent decision in Amgen v. Sanofi puts a spotlight on enablement of functionally defined claims. Future developments may shed light on a number of remaining questions for patent applicants. Here are five areas to watch: 1. What is the impact on other technology? The Court emphasized that “aspects of antibody science remain…

In a unanimous ruling, the Supreme Court of the United States (SCOTUS) addressed the enablement requirement under Section 112 of the Patent Act, placing this into sharper focus with the Amgen v. Sanofi case. This landmark decision underlines an essential pillar of patent law, striking a delicate balance between acknowledging the creativity of inventors through…

Horizon Therapeutics (HZNP) rose 1% amid a report that a Federal Trade Commission closed door meeting on Friday is likely unrelated to the Amgen's (AMGN) planned acquisition. The...

The biotech company shuffled deals around yesterday, dropping a four-year collaboration with Israel’s Entera Bio and picking a new partner in Massachusetts-based TScan Therapeutics.

TScan Therapeutics (TCRX) added ~122% Monday in reaction to a multi-year deal with Amgen (AMGN) to identify therapeutic targets in Crohn's disease. Read more here.